Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-033091
Filing Date
2024-08-19
Accepted
2024-08-19 16:32:42
Documents
55
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 997916
2 ex31-1.htm EX-31.1 13380
3 ex31-2.htm EX-31.2 13746
4 ex32-1.htm EX-32.1 11249
  Complete submission text file 0001493152-24-033091.txt   4853588

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE arth-20240630.xsd EX-101.SCH 36956
6 XBRL CALCULATION FILE arth-20240630_cal.xml EX-101.CAL 39810
7 XBRL DEFINITION FILE arth-20240630_def.xml EX-101.DEF 157338
8 XBRL LABEL FILE arth-20240630_lab.xml EX-101.LAB 290987
9 XBRL PRESENTATION FILE arth-20240630_pre.xml EX-101.PRE 236445
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 673430
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-54986 | Film No.: 241221077
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)